Epididase is a novel compound designed to interfere with the interaction between amyloid and glycosaminoglycans, thereby inhibiting the aggregation of amyloid fibrils and their deposition in tissues. Epididase slows down the progression of AA amyloidosis associated nephropathy and may be applicable to other types of amyloidosis.